Two cancer biotechs merge, raise cash as sector-wide downturn continues
BioPharma
Source: biopharmadive.com
Page 2 - Tyme Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tyme Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tyme Technologies Today - Breaking & Trending Today
Investor Alert - The M&A Class Action Firm Announces an Investigation of Tyme Technologies, Inc.
/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...
Source: prnewswire.com
Elevar Therapeutics Names Dr. Jan M. Van Tornout Chief
SALT LAKE CITY, June 28, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating...
Source: globenewswire.com
Tyme Technologies, Inc. (NASDAQ:TYME) Major Shareholder Michael Demurjian Sells 60,000 Shares
Tyme Technologies, Inc. (NASDAQ:TYME – Get Rating) major shareholder Michael Demurjian sold 60,000 shares of the stock in a transaction dated Tuesday, June 14th. The stock was sold at an average price of $0.25, for a total transaction of $15,000.00. Following the completion of the transaction, the insider now owns 23,228,846 shares of the company’s […]
Source: etfdailynews.com
Tyme Technologies, Inc. (NASDAQ:TYME) Director Steve Hoffman Sells 78,125 Shares
Tyme Technologies, Inc. (NASDAQ:TYME – Get Rating) Director Steve Hoffman sold 78,125 shares of the company’s stock in a transaction that occurred on Wednesday, June 8th. The shares were sold at an average price of $0.27, for a total value of $21,093.75. Following the completion of the transaction, the director now directly owns 20,256,941 shares […]
Source: etfdailynews.com